Sinocelltech Group Limited

Shanghai Stock Exchange 688520.SS

Sinocelltech Group Limited Cash and Short-Term Investments for the year ending December 31, 2023: USD 41.32 M

Sinocelltech Group Limited Cash and Short-Term Investments is USD 41.32 M for the year ending December 31, 2023, a -70.66% change year over year. Cash and short-term investments are the sum of cash and short-term investments, representing the company's liquid assets.

Sinocelltech Group Limited Cash and Short-Term Investments for the year ending December 31, 2022 was USD 140.84 M, a 156.05% change year over year.
Sinocelltech Group Limited Cash and Short-Term Investments for the year ending December 31, 2021 was USD 55.00 M, a -62.22% change year over year.
Sinocelltech Group Limited Cash and Short-Term Investments for the year ending December 31, 2020 was USD 145.58 M, a 518.93% change year over year.
Sinocelltech Group Limited Cash and Short-Term Investments for the year ending December 31, 2019 was USD 23.52 M, a 2,242.18% change year over year.

Key data

Date	Cash and Short-Term Investments	Receivables	Inventory	Goodwill

Shanghai Stock Exchange: 688520.SS

Sinocelltech Group Limited

CEO	Dr. Liangzhi Xie Ph.D.
IPO Date	June 22, 2020
Location	China
Headquarters	No. 31 Kechuang 7th Street
Employees	2,313
Sector	Healthcare
Industries Biotechnology 3D Printing

Description

Sinocelltech Group Limited, a biotech company, focuses on the development of technologies for the development and manufacturing of recombinant proteins, monoclonal antibodies, and vaccines in China. The company is based in Beijing, China.

Key trends

Past 5 years